Xcellerex, Inc. and Itero Biopharmaceuticals, Inc. announced today that they have signed a Letter of Intent to enter into a strategic collaboration for the production of Itero's lead product, an ...

Xcellerex, Inc. announced today that Guy Broadbent has been appointed President and Chief Executive Officer and a member of the company's board of directors. Mr. Broadbent succeeds Joseph Zakrzewski, ...

Xcellerex will leverage its XDR bioreactors and FlexFactory platform to allow future scale-up. Xcellerex and Humacyte signed a collaboration agreement under which Xcellerex will develop a single-use ...

Gallus Acquiring FlexFactory® Bioproduction Lines and Single-Use Bioreactors; Xcellerex Partners to Help Customers Gain Access to Commercial Biomanufacturing Facility MARLBOROUGH, Mass. & ST.

Xcellerex’ products have reportedly been used in more than 20 therapeutic proteins and vaccines. GE Healthcare is taking over Xcellerex, a supplier of biomanufacturing technologies. The company says ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc., which provides next generation manufacturing services and systems for biotherapeutics and vaccines based on proprietary, single use, disposable ...

Xcellerex Inc., a privately held developer of disposable systems used in manufacturing biologicals, said it has signed an agreement with SK Chemicals Co. Ltd. of South Korea to develop SK’s vaccines ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The health care unit of GE (NYSE: GE) on Wednesday said it ...

GE Healthcare, a unit of GE announced today it has reached an agreement to acquire Xcellerex, Inc. a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry.

The APS system comes equipped with filter switching, liquid management, and cell bleed to reduce risk of human error and increase process robustness. Cytiva announced ...